BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Derma Sciences, Inc. Reports Second Quarter 2008 Results

  August 15, 2008

   · 

  4 min read
• FDA

  CV Therapeutics, Inc. Receives European Approval for the Brand Name Ranexa(R)

  August 15, 2008

   · 

  2 min read
• Business

  Vermillion Announces Second Quarter 2008 Financial Results and Business Progress

  August 15, 2008

   · 

  6 min read
• Business

  Ardea Biosciences, Inc. Announces Progress of Clinical Development Programs and Reports Second Quarter and Year-to-Date 2008 Financial Results

  August 15, 2008

   · 

  6 min read
• Business

  Cell Therapeutics, Inc. to Report 2008 Second Quarter Financial Results on August 18

  August 15, 2008

   · 

  1 min read
• Drug Development

  Starpharma Holdings Ltd VivaGel(R) New Clinical Trial Commences

  August 15, 2008

   · 

  1 min read
• Business

  INC Research, Inc. Appoints Operations Vice President to CNS Division

  August 15, 2008

   · 

  2 min read
• FDA

  Prestwick Pharmaceuticals, Inc.'s XENAZINE(R) Approved by FDA for Patients with Chorea Associated with Huntington’s Disease

  August 15, 2008

   · 

  3 min read